A 25-Year Journey in the Fight Against Pulmonary Arterial Hypertension at a Korean Center: What Has Changed and What Is Missing?
作者信息
Choi Jung Hyun, Park Jae Hyeong
机构信息
Division of Cardiology, Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of Medicine and Biomedical Research Institute, Busan, Korea.
Division of Cardiology Department of Internal Medicine, School of Medicine, Chungnam National University Hospital, Chungnam National University, Daejeon, Korea.
出版信息
Korean Circ J. 2024 Oct;54(10):651-652. doi: 10.4070/kcj.2024.0314.
Abstract
摘要
相似文献
1
A 25-Year Journey in the Fight Against Pulmonary Arterial Hypertension at a Korean Center: What Has Changed and What Is Missing?韩国一家医疗中心对抗肺动脉高压的25年历程：有哪些变化？又缺失了什么？
Korean Circ J. 2024 Oct;54(10):651-652. doi: 10.4070/kcj.2024.0314.
2
15 years journey of idiopathic pulmonary arterial hypertension with BMPR2 mutation.伴有骨形态发生蛋白受体2（BMPR2）突变的特发性肺动脉高压15年病程
Clin Hypertens. 2019 Oct 1;25:22. doi: 10.1186/s40885-019-0127-7. eCollection 2019.
3
Safety and effectiveness of ambrisentan in real clinical practice in pulmonary arterial hypertension: Results from the Korean post-marketing surveillance.在真实临床实践中安立生坦治疗肺动脉高压的安全性和有效性：来自韩国上市后监测研究的结果。
Pharmacoepidemiol Drug Saf. 2023 Dec;32(12):1387-1394. doi: 10.1002/pds.5671. Epub 2023 Jul 27.
4
Baseline Characteristics of the Korean Registry of Pulmonary Arterial Hypertension.韩国肺动脉高压注册研究的基线特征
J Korean Med Sci. 2015 Oct;30(10):1429-38. doi: 10.3346/jkms.2015.30.10.1429. Epub 2015 Sep 12.
5
Growing up with Idiopathic Pulmonary Arterial Hypertension: An Arduous Journey.与特发性肺动脉高压相伴成长：一段艰辛的旅程。
Pediatr Rep. 2023 May 5;15(2):301-310. doi: 10.3390/pediatric15020026.
6
Survival benefits of warfarin in Korean patients with idiopathic pulmonary arterial hypertension.华法林对韩国特发性肺动脉高压患者的生存益处。
Korean J Intern Med. 2015 Nov;30(6):837-45. doi: 10.3904/kjim.2015.30.6.837. Epub 2015 Oct 30.
7
Pulmonary arterial hypertension in Saudi Arabia: Patients' clinical and physiological characteristics and hemodynamic parameters. A single center experience.沙特阿拉伯的肺动脉高压：患者的临床和生理特征及血流动力学参数。单中心经验。
Ann Thorac Med. 2014 Oct;9(4):209-15. doi: 10.4103/1817-1737.140127.
8
Long-term outcomes of surgery for chronic thromboembolic pulmonary hypertension compared with medical therapy at a single Korean center.韩国一家中心慢性血栓栓塞性肺动脉高压手术与药物治疗的长期疗效比较
Korean J Intern Med. 2017 Sep;32(5):855-864. doi: 10.3904/kjim.2016.049. Epub 2016 Oct 13.
9
Maternal and Fetal Outcomes in Pregnant Women with Pulmonary Arterial Hypertension: A Single-Center Experience and Review of Current Literature.肺动脉高压孕妇的母婴结局：单中心经验及文献复习。
Anatol J Cardiol. 2022 Dec;26(12):902-913. doi: 10.5152/AnatolJCardiol.2022.1762.
10
Outcome of patients with pulmonary arterial hypertension referred for lung transplantation: a 14-year single-center experience.肺动脉高压患者肺移植转诊的结果：14 年单中心经验。
J Thorac Cardiovasc Surg. 2012 Apr;143(4):910-8. doi: 10.1016/j.jtcvs.2011.08.055. Epub 2012 Feb 4.
本文引用的文献
1
Treatment algorithm for pulmonary arterial hypertension.肺动脉高压治疗算法。
Eur Respir J. 2024 Oct 31;64(4). doi: 10.1183/13993003.01325-2024. Print 2024 Oct.
2
A Single Center Experience of Pulmonary Arterial Hypertension Management in Korea: A 25-Year Comparative Analysis Following the Introduction of Targeted Therapy.韩国肺动脉高压管理的单中心经验：靶向治疗引入后的25年对比分析
Korean Circ J. 2024 Oct;54(10):636-650. doi: 10.4070/kcj.2023.0316. Epub 2024 Jun 24.
3
Pulmonary arterial hypertension treatment: an individual participant data network meta-analysis.肺动脉高压治疗：个体参与者数据网络荟萃分析。
Eur Heart J. 2024 Jun 1;45(21):1937-1952. doi: 10.1093/eurheartj/ehae049.
4
Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysis.结缔组织病合并肺动脉高压患者的治疗策略和生存：COMPERA 分析。
Rheumatology (Oxford). 2024 Apr 2;63(4):1139-1146. doi: 10.1093/rheumatology/kead360.
5
Epidemiology of PAH in Korea: An Analysis of the National Health Insurance Data, 2002-2018.韩国肺动脉高压的流行病学：2002 - 2018年国民健康保险数据分析
Korean Circ J. 2023 May;53(5):313-327. doi: 10.4070/kcj.2022.0231.
6
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Heart J. 2022 Oct 11;43(38):3618-3731. doi: 10.1093/eurheartj/ehac237.
7
Effectiveness and Outcome of Pulmonary Arterial Hypertension-Specific Therapy in Japanese Patients With Pulmonary Arterial Hypertension.肺动脉高压特异性治疗在日本肺动脉高压患者中的疗效和结局。
Circ J. 2017 Dec 25;82(1):275-282. doi: 10.1253/circj.CJ-17-0139. Epub 2017 Jul 26.
Zotero 插件